In our latest IPWatchdog Unleashed podcast, I spoke with Rob Sahr, shareholder at Wolf Greenfield and co-chair of our 2025 Life Sciences Masters™ program. Our conversation zeroed in on a hard truth the public rarely sees: moving a molecule from early discovery to an FDA-approved therapy requires a chain of scientific and economic miracles-and every one of them leans on a reliable patent system.
Kraken, one of the longest-running crypto exchanges, has taken a major step toward going public, filing for a U.S. initial public offering (IPO) through its parent company, Payward, Inc. The draft S-1 registration statement was submitted to the Securities and Exchange Commission (SEC), formally placing Kraken in the IPO pipeline. The confidential filing follows an $800 million fundraising round completed on Tuesday, which valued Kraken at $20 billion.
CoinDCX confirmed to TechCrunch that the latest funding is an investment of new capital by Coinbase. The U.S. exchange has been an investor in CoinDCX since 2020 and last backed the Indian exchange in its Series D round in 2022 through its venture capital arm, Coinbase Ventures. Notably, the funding comes just months after CoinDCX suffered a security breach in July that led to the theft of around $44 million worth of assets.
